OptimizeRx (OPRX) Receivables - Net (2010 - 2026)

OptimizeRx's Receivables - Net history runs 17 years deep, the most recent figure standing at $32.0 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 2.23% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at $32.0 million (down 2.23% YoY), while the FY2025 annual figure was $37.8 million, down 1.2% from the prior year.
• Receivables - Net came in at $32.0 million for Q1 2026 at OptimizeRx, down from $37.8 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $38.2 million in Q4 2024 to a low of $2.8 million in Q1 2022.
• A 5-year average of $23.3 million and a median of $26.3 million in 2024 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net slumped 80.83% in 2022 and jumped 724.22% in 2024, its largest moves.
• OptimizeRx's Receivables - Net stood at $22.2 million in 2022, then jumped by 63.63% to $36.3 million in 2023, then grew by 5.4% to $38.2 million in 2024, then dropped by 1.2% to $37.8 million in 2025, then declined by 15.27% to $32.0 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $32.0 million, $37.8 million, and $32.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison